Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950135-98-002073
Filing Date
1998-03-31
Accepted
1998-03-31 00:00:00
Documents
8
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 TRANSCEND THERAPEUTICS, INC. 10-K405 203147
2 AMENDED AND RESTATED 1994 EQUITY INCENTIVE PLAN EX-10.1 36650
3 LICENSE AGREEMENT WITH BAXTER INTERNATIONAL, INC. EX-10.4 42900
4 LICENSE AGREEMENT WITH NESTLE, S.A. EX-10.5 43190
5 FORM OF WARRENT AGREEMENT EX-10.12 24860
6 CONSENT OF ERNST & YOUNG LLP EX-23 656
7 FINANCIAL DATA SCHEDULE FOR YEAR END 12/31/97 EX-27.1 2314
8 RESTATED F.D.S. FOR YEAR ENDED 12/31/96 EX-27.2 2326
  Complete submission text file 0000950135-98-002073.txt   358338
Mailing Address 640 MEMORIAL DR 3W CAMBRIDGE MA 02139
Business Address 640 MEMORIAL DR 3W CAMBRIDGE MA 02139 6173741200
TRANSCEND THERAPEUTICS INC (Filer) CIK: 0001020910 (see all company filings)

EIN.: 043174575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-22383 | Film No.: 98581487
SIC: 2836 Biological Products, (No Diagnostic Substances)